Daniella Kranjac
InvestorGeneral Partner at Avant Bio
New York, New York
Writes $3M β $10M checks Β· typically $5M
About
Senior figure at AVANT BIO, featured in 100 Women in Finance's profile series and nominated as an INNOVATE100 honoree.
Experience
- Avant Bio LLCFounding GPcurrent2023 β presentNew York City Metropolitan Area
- Alpenglow BiosciencesBoard Membercurrent2023 β present
- CellFEBoard Membercurrent2022 β present
- Curi BioBoard Membercurrent2023 β present
- EnvisagenicsInvestor / Board Observer (2016-2022)current2017 β presentNew York City Metropolitan Area
- Intrepid LabsBoard Observercurrent2025 β presentToronto, Ontario, Canada
- RoosterBio Inc.Board Membercurrent2019 β present
- Virica BiotechBoard Membercurrent2021 β presentOttawa, Ontario, Canada
- Xcell BiosciencesBoard Observercurrent2021 β presentSan Francisco Bay Area
- Dynamk Consulting LLCFounder & CEOcurrent2015 β presentNew Jersey, USA
- Dynamk CapitalFounding Partnercurrent2017 β presentNew York City Metropolitan Area
- Global Women in VCMembercurrent2020 β present
- Vernal BiosciencesBoard Member2023 β 2025
- FloDesign SonicsBoard Member2017 β 2019
- GE HealthcareGlobal Head, Enterprise Solutions2014 β 2015Global virtual team: USA, Europe, Brazil, Australia, China, Singapore
- GE HealthcareHead of Business Development2013 β 2014Americas, Europe, Middle East
- GE HealthcareEnterprise Solutions Business Development2010 β 2013North America, Brazil & Latin America
- GE HealthcareIntegration Leader and Head, Commercial Operations2007 β 2010
- Wave Biotech LLCCo-Founder, Vice President1999 β 2007
Education
- NYU Stern School of BusinessExecutive MBA2010 β 2012
- Harvard Business SchoolExecutive Education, Private Equity and Venture Capital
- Columbia Business SchoolExecutive Education Program, Finance and Accounting for the non-Financial Executive
- Stevens Institute of TechnologyB.E., Chemical Engineering/Biochemical Engineering
Skills & more
Strategy99Management41Leadership36Biotechnology99Life Sciences77Start-ups70Business Development67Mergers & Acquisitions27Biopharmaceuticals36Product Management36Commercialization31Entrepreneurship24
+6 more
Technology TransferMarketing StrategyGMPProduct DevelopmentCross-functional Team LeadershipPharmaceutical IndustryLanguages Croatian
From Daniella's professional profile.
Same school
Also attended NYU Stern School of Business367
Luna SchmidInvestor at GV (Google Ventures)Kaz TeradaVenture Advisor at Monta Vista CapitalNeil FongManaging Director Asia at Burda Principal InvestmentsAlex TosoliniAdvisor at CincyTechMax WechterSenior Director of AI at Lerer HippeauTom MonahanFormer Chairman & CEO, CEB at MissionOG
+ 361 more
Also attended Harvard Business School1,777
Brad GerstnerFounder & CEO of Altimeter CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesJim BreyerFounder & CEO of Breyer CapitalTim DraperFounder of Draper AssociatesMike Maples JrCo-founding Partner at FloodgateMamoon HamidPartner at Kleiner Perkins
+ 1,771 more
Also attended Columbia Business School576
Aryo TehranianManaging Director at Mayfair Equity PartnersYibo NianInvestment Director at Intel CapitalKesha CashFounder & General Partner at Impact America FundMahati SridharPartner, Rise of the Rest at RevolutionGiuseppe IademarcoHead of Global Partnership at P101 VenturesWendy XiaoPartner at Northzone
+ 570 more
Also attended Stevens Institute of Technology18
Srinivas RaoInvestor at Phoenix Venture PartnersLindsay GoeddelInvestor at Constellation Technology VenturesGreg McAdooGeneral Partner at BoltNikos VogiatzisPartner at Corallia VenturesMiriam Moreno-HerediaOperations Associate at Accial CapitalGarry TurkingtonInvestor at CapitalT
+ 12 more
Shared employers
Also worked at Alpenglow Biosciences1
Also worked at CellFE3
Also worked at Curi Bio1
Also worked at Envisagenics1
Deals Β· 4
Alpenglow Biosciences, Inc.Board seat
via Avant Bio Β· filed Dec 2025 Β· $3M raise
RoosterBioBoard seat
via Avant Bio Β· filed Jul 2024 Β· $12M raise
Virica Biotech Inc.Board seat
via Avant Bio Β· filed May 2024
Vernal Biosciences, Inc.Board seat
via Avant Bio Β· filed Jun 2023 Β· $41M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Avant Bio
Network5
Alex Iskold
Founder and Partner at 2048 Ventures
Jessica Davis
Principal at Avant Bio
Ole Henrik Bang-Andreasen
Investor at Avant Bio
Peter Lee
Investor at Avant Bio
Zavain Dar
Founder and Managing Partner at Dimension Capital
Investors connected to Daniella in public investor directories β a warm-intro map.





























